Infliximab therapy for moderately severe Crohn&rsquo;s disease and ulcerative colitis: a retrospective comparison over 6 years

Infliximab therapy for moderately severe Crohn&rsquo;s disease and ulcerative colitis: a retrospective comparison over 6 years

Raed Alzafiri1, Christina A Holcroft2, Paula Malolepszy1, Albert Cohen1, Andrew Szilagyi11Jewish General Hospital, Division of Gastroenterology, Department of Medicine, McGill University School of Medicine, Montreal, Quebec, Canada; 2Centre for Clinical Epidemiology and Community Studies, McGill Uni...

Full description

Bibliographic Details
Main Authors:	Raed Alzafiri, Christina A Holcroft, Paula Malolepszy, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-01-01
Series:	Clinical and Experimental Gastroenterology
Online Access:	http://www.dovepress.com/infliximab-therapy-for-moderately-severe-crohnrsquos-disease-and-ulcer-a6138

Similar Items

Infliximab to treat Crohn&rsquo;s disease: an update
by: Criscuoli V, et al.
Published: (2011-09-01)

Infliximab in the treatment of severe ulcerative colitis
by: J. Maté Jiménez

Maintenance treatment with infliximab for the management of Crohn&rsquo;s disease in adults
by: Renato Caviglia, et al.
Published: (2009-01-01)

Infliximab therapy in pediatric Crohn&rsquo;s disease: a review
by: Kalyan Ray Parashette, et al.
Published: (2010-06-01)

Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn&rsquo;s disease
by: Glen A Doherty, et al.
Published: (2009-12-01)

Infliximab in ulcerative colitis
by: Avi Levin, et al.
Published: (2008-09-01)

The role of vedolizumab in patients with moderate-to-severe Crohn’s disease and ulcerative colitis
by: Neal Shahidi, et al.
Published: (2016-05-01)

Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn’s disease?
by: Gilroy L, et al.
Published: (2014-05-01)

Infliximab for the treatment of ulcerative colitis
by: C Hyde, et al.
Published: (2009-10-01)

Profile of infliximab in the treatment of pediatric Crohn’s disease
by: Kierus J, et al.
Published: (2015-06-01)

<title language="eng">Infliximab in the treatment of severe ulcerative colitis
by: J. Maté Jiménez
Published: (2004-02-01)

A comparison of short-term therapeutic efficacy between infliximab and tacrolimus for moderate to severe ulcerative colitis
by: Yamagami Hirokazu, et al.
Published: (2017-09-01)

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?
by: Viscido A, et al.
Published: (2019-04-01)

The Use of Infliximab for Treatment of Hospitalized Patients with Acute Severe Ulcerative Colitis
by: B Bressler, et al.
Published: (2008-01-01)

Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland
by: Pawel Petryszyn, et al.
Published: (2020-08-01)

Colitis ulcerosa grave, con megacolon tóxico, resuelta con infliximab Severe ulcerative colitis and toxic megacolon resolved with infliximab therapy
by: M. Castro Fernández, et al.
Published: (2007-07-01)

The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
by: Hyun Il Seo, et al.
Published: (2014-07-01)

Infliximab for the treatment of acute exacerbations of ulcerative colitis
by: S Bryan, et al.
Published: (2010-05-01)

All That Bleeds Is Not Infliximab-Refractory Ulcerative Colitis
by: JK Law, et al.
Published: (2009-01-01)

Intensification of maintenance therapy with infliximab in ulcerative colitis
by: Francesc Casellas

INFLIXIMAB IN THE TREATMENT OF SEVERE STEROID-REFRACTORY ULCERATIVE COLITIS – A CASE REPORT
by: Darja Urlep, et al.
Published: (2004-04-01)

Ulcerative colitis or Crohn’s disease?
by: R. G. Artamonov, et al.
Published: (2016-03-01)

Early Serum Infliximab Levels in Pediatric Ulcerative Colitis
by: Jennifer C. C. deBruyn, et al.
Published: (2021-07-01)

Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
by: Muhammad Mirza, et al.
Published: (2018-01-01)

Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
by: Garrett Lawlor, et al.
Published: (2009-12-01)

Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis
by: Remo Panaccione, et al.
Published: (2008-01-01)

Promising effect of infliximab on the extent of involvement in ulcerative colitis
by: Peyman Adibi, et al.
Published: (2011-01-01)

Oropharyngeal Crohn&rsquo;s disease
by: Rachid Mohamed, et al.
Published: (2008-12-01)

Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China
by: Ting Zhou, et al.
Published: (2021-08-01)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
by: Matsumoto S, et al.
Published: (2018-07-01)

Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
by: Fazia A. Mir, et al.
Published: (2018-02-01)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
by: Assasi Nazila, et al.
Published: (2009-12-01)

Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab Pioderma gangrenoso asociado a colitis ulcerosa: respuesta a infliximab
by: A. López San Román, et al.
Published: (2004-06-01)

Infliximab in Crohn's disease Infliximab en la enfermedad de Crohn
by: L. Rodrigo Sáez
Published: (2004-06-01)

Natalizumab in the treatment of Crohn&rsquo;s disease
by: Danila Guagnozzi, et al.
Published: (2008-06-01)

Adalimumab for the treatment of Crohn&rsquo;s disease
by: Andrea Cassinotti, et al.
Published: (2008-09-01)

Body Composition in Crohn’s Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration
by: Dawesh P. Yadav, et al.
Published: (2017-01-01)

Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars
by: O. V. Knyazev, et al.
Published: (2021-02-01)

Review of pregnancy in Crohn’s disease and ulcerative colitis
by: Robyn Laube, et al.
Published: (2021-05-01)

Mucosal Barrier in Ulcerative Colitis and Crohn’s Disease
by: A. E. Dorofeyev, et al.
Published: (2013-01-01)